logo True scholar network
Back to Top
Visit Website

Immunotherapy (Immunotherapy)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Cancer immunotherapy
  • Allergen immunotherapy
  • chemo/radio immunotherapy

    • +3

e-ISSN :

1750-7448

Issue Frequency :

Semi-monthly

Impact Factor :

2.7

p-ISSN :

1750-743X

Est. Year :

2009

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

GOOGLE SCHOLAR

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

Immunotherapy is a subscription-based peer-reviewed journal covering both preclinical research and clinical research, as well as the applications of immunotherapy. The journal’s audience includes researchers and clinicians interested in immunotherapy for cancers and other diseases. Journal coverage includes key areas such as: • Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines • Combined chemo/radio immunotherapy in cancer treatment • Biomarkers for personalized cancer immunotherapy • Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy • Restorative immunotherapy for HIV and other immunocompromised patients • Suppressive immunotherapy for autoimmunity diseases and transplantation • Basic science of immunotherapeutic approaches • Drug–immune system interactions • Drug delivery systems, drug combinations and drug–drug interactions • Summaries evaluating newly approved immunotherapeutic agents • Newly identified immune targets of drugs • Results of recent findings and clinical trials relevant to the field of immunotherapy • Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research


Immunotherapy (Immunotherapy) is :

International, Peer-Reviewed, Open Access, Refereed, Cancer immunotherapy, Allergen immunotherapy, chemo/radio immunotherapy, Drug delivery systems, drug combinations, outcomes research , Online or Print, Semi-monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 1750-743X, E-ISSN - 1750-7448, Established in - 2009, Impact Factor - 2.7

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
ISSN Portal

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile